Skip to main content
Rena Xian, MD, Pathology, Baltimore, MD

RenaRuiyaXianMD

Pathology Baltimore, MD

Hematopathology, Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Dr. Xian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Xian's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Molecular Genetic Pathology, 2014 - 2015
  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematopathology, 2013 - 2014
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2009 - 2013
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2009

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2018 - 2025
  • CA State Medical License
    CA State Medical License 2014 - 2019
  • PA State Medical License
    PA State Medical License 2009 - 2014
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Pathology - Hematology
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Journal Articles

  • Clinical Validation of Coexisting Driver Mutations in Colorectal Cancers  
    Junaid Ibrahim, James R Eshleman, Gang Zheng, Christopher D Gocke, Rena Xian, ScienceDirect

Authored Content

  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020
  • Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing–Based Hematologic Malignancy Assays with Survey Material–Specific Differences in Variant FrequenciesJanuary 2020